Target Price | $77.46 |
Price | $54.39 |
Potential | 42.42% |
Number of Estimates | 32 |
32 Analysts have issued a price target Nike 2026 . The average Nike target price is $77.46. This is 42.42% higher than the current stock price. The highest price target is $120.00 120.63% , the lowest is $40.00 26.46% . | |
A rating was issued by 41 analysts: 21 Analysts recommend Nike to buy, 18 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nike stock has an average upside potential 2026 of 42.42% . Most analysts recommend the Nike stock at Purchase. |
33 Analysts have issued a sales forecast Nike 2025 . The average Nike sales estimate is $45.9b . This is 4.26% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $46.2b 3.50% , the lowest is $45.0b 6.06% .
This results in the following potential growth metrics:
2024 | $51.4b | 0.38% |
---|---|---|
2025 | $45.9b | 10.75% |
2026 | $45.4b | 1.00% |
2027 | $47.9b | 5.54% |
2028 | $53.0b | 10.53% |
2029 | $54.9b | 3.68% |
24 Analysts have issued an Nike EBITDA forecast 2025. The average Nike EBITDA estimate is $4.4b . This is 21.25% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.6b 16.32% , the lowest is $4.1b 25.30% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.8b | 13.68% |
---|---|---|
2025 | $4.4b | 36.23% |
2026 | $4.0b | 9.18% |
2027 | $5.0b | 26.20% |
2028 | $6.6b | 32.02% |
2029 | $7.9b | 19.16% |
2024 | 13.31% | 13.25% |
---|---|---|
2025 | 9.51% | 28.54% |
2026 | 8.72% | 8.31% |
2027 | 10.43% | 19.61% |
2028 | 12.46% | 19.46% |
2029 | 14.32% | 14.93% |
14 Nike Analysts have issued a net profit forecast 2025. The average Nike net profit estimate is $3.1b . This is 29.36% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.3b 26.31% , the lowest is $3.0b 32.23% .
This results in the following potential growth metrics and future Net Margins:
2024 | $5.5b | 15.48% |
---|---|---|
2025 | $3.1b | 43.00% |
2026 | $2.8b | 9.76% |
2027 | $3.6b | 26.63% |
2028 | $4.9b | 36.23% |
2029 | $6.2b | 26.28% |
2024 | 10.72% | 15.04% |
---|---|---|
2025 | 6.85% | 36.11% |
2026 | 6.24% | 8.91% |
2027 | 7.49% | 20.03% |
2028 | 9.23% | 23.23% |
2029 | 11.24% | 21.78% |
14 Analysts have issued a Nike forecast for earnings per share. The average Nike EPS is $2.13 . This is 29.24% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.22 26.25% , the lowest is $2.04 32.23% .
This results in the following potential growth metrics and future valuations:
2024 | $3.73 | 15.48% |
---|---|---|
2025 | $2.13 | 42.90% |
2026 | $1.92 | 9.86% |
2027 | $2.43 | 26.56% |
2028 | $3.31 | 36.21% |
2029 | $4.18 | 26.28% |
Current | 18.10 | 30.73% |
---|---|---|
2025 | 25.58 | 41.33% |
2026 | 28.35 | 10.83% |
2027 | 22.39 | 21.02% |
2028 | 16.43 | 26.62% |
2029 | 13.01 | 20.82% |
Based on analysts' sales estimates for 2025, the Nike stock is valued at an EV/Sales of 1.78 and an P/S ratio of 1.75 .
This results in the following potential growth metrics and future valuations:
Current | 1.71 | 35.23% |
---|---|---|
2025 | 1.78 | 4.30% |
2026 | 1.80 | 1.01% |
2027 | 1.71 | 5.25% |
2028 | 1.54 | 9.53% |
2029 | 1.49 | 3.56% |
Current | 1.68 | 35.80% |
---|---|---|
2025 | 1.75 | 4.45% |
2026 | 1.77 | 1.01% |
2027 | 1.68 | 5.24% |
2028 | 1.52 | 9.53% |
2029 | 1.46 | 3.55% |
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Apr 11 2025 |
Stifel |
Hold
➜
Hold
|
Unchanged | Apr 10 2025 |
Stifel |
Hold
➜
Hold
|
Unchanged | Apr 04 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Mar 21 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Mar 21 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 21 2025 |
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Apr 11 2025 |
Unchanged
Stifel:
Hold
➜
Hold
|
Apr 10 2025 |
Unchanged
Stifel:
Hold
➜
Hold
|
Apr 04 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Mar 21 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Mar 21 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Mar 21 2025 |
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Mar 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.